Labcorp names Thomas Pike as president and CEO of clinical development business spin-off


Labcorp's planned spin-off of its clinical development business has a leader – Thomas Pike, an industry veteran with more than 30 years of experience.

Previous Ex-Raleigh financier tries to maneuver his way out of prison, again
Next New investments push KeyCare Series A to more than $27M